Neola medical: Funded to continue clinical validation - Redeye
Redeye interviewed Neola Medical's CEO, Hanna Sjöström, following the company's Q2 2026 report. We discussed the report, the company's cash situation, and the upcoming pre-clinical and clinical study.
ANNONS
Redeye interviewed Neola Medical's CEO, Hanna Sjöström, following the company's Q2 2026 report. We discussed the report, the company's cash situation, and the upcoming pre-clinical and clinical study.
